CME Group executed its first block trade in Bitcoin Cash (BCH) and Uniswap (UNI) futures, marking an expansion of its single-asset crypto derivatives offerings. This move follows earlier additions of futures for Cardano, Chainlink, Stellar, Avalanche, and Sui, contributing to nearly $2 billion in notional value growth this year. CME's crypto futures and options have seen strong activity in 2026, with average daily volumes exceeding 242,000 contracts and open interest nearing 240,000 contracts. This expansion highlights growing institutional interest in diverse cryptocurrency products on regulated exchanges.
The first block trade in CME's Bitcoin Cash and Uniswap futures is noted here alongside Pluang's market data for major cryptocurrencies. For readers following crypto assets on Pluang as of Oct 21, 2026 03:41 WIB, 45 of 50 major cryptocurrencies rose while 4 fell. Among notable movers, COTI gained 5.41% to Rp201 with a 67% sell order activity, contrasting with AXS which rose 5.20% to Rp18,925 but saw 100% sell orders, and SNX increased 4.96% to Rp4,060 with 75% buy orders and a shorter typical hold time of 70 days compared to COTI's 121 days.
Moody's is expected to report Q3 2026 earnings of around $4.25 per share on revenue near $2.08 billion, driven by steady demand for credit ratings and growth in Moody's Analytics, especially from recurring subscriptions and AI tools. While Moody's In...
Raymond James increased its price target for Rapport Therapeutics to $86 following positive Phase 2 trial results of RAP-219, a drug treating acute bipolar mania. The trial showed statistically significant improvement in patients and a favorable safe...
Heartland Express reported a third-quarter 2026 revenue decline of 8.7% to $179.5 million, missing analyst estimates. Despite lower revenue, the company returned to profitability with a net income of $1.0 million, compared to a loss last year. The op...
Catholic Medical Mission Board (CMMB) held a ribbon-cutting ceremony for its new Distribution Center at the Brethren Service Center in New Windsor, Maryland. This move enhances CMMB's Access to Medicines Program by expanding operational capacity and ...
Piper Sandler upgraded Myriad Genetics from Underweight to Neutral and set a $5.00 price target after the company agreed to sell its prenatal health testing business to Labcorp for $210 million in cash. This sale includes several prenatal tests and i...
